MoneyWeek highlights Cameco (NYSE: CCJ) as a key beneficiary of the global nuclear renaissance, driven by rising demand for zero-carbon baseload power to support AI data centers and geopolitical supply chain uncertainties. The article notes that while uranium prices are already rising, a significant supply shortfall is expected from 2033 onwards, with production projected to meet only half of demand by 2041. This structural deficit positions Cameco to capture higher margins through its long-term contract strategy rather than relying on volatile spot markets.
Cameco's financial performance has been robust, with 2025 revenue increasing 11% to $3.5 billion and adjusted diluted earnings per share surging 321% to C$1.44. The company secured a major nine-year agreement in March 2026 with India to supply nearly 22 million pounds of uranium ore, valued at an estimated C$2.6 billion. Analysts project long-term contract prices reaching up to C$200 per pound by 2033, reflecting the tightening supply landscape and growing global fleet of nuclear reactors.
Beyond mining, Cameco benefits from its vertical integration through a 49% stake in Westinghouse Electric Company, which is developing small modular reactors and securing US government financing for new builds worth at least $80 billion. Additionally, Cameco holds a 49% interest in Global Laser Enrichment (GLE), which possesses an exclusive license for third-generation laser enrichment technology (SILEX). These strategic partnerships and technological assets provide multiple growth drivers alongside the core uranium supply business.
📈 Global uranium supply expected to be only 50% of demand by 2041.
💰 2025 revenue rose 11% to $3.5 billion with EPS up 321%.
🤝 Signed nine-year India deal for 22 million pounds worth C$2.6 billion.
🔋 Uranium prices averaged C$91.3/lb in Q4 2025, targeting C$200 by 2033.
📉 Analysts project one-year share price target of C$185 from recent C$123.
📈 Cameco is positioned to benefit from a projected global uranium supply shortfall starting in 2033, with production expected to be only 50% of demand by 2041.
💰 The company reported 2025 revenue up 11% to $3.5 billion and adjusted diluted earnings per share up 321% to C$1.44.
🤝 Cameco signed a nine-year agreement in March 2026 with India to supply nearly 22 million pounds of uranium ore, valued at an estimated C$2.6 billion.
🔋 Uranium prices rose to an average of C$91.3 per pound in Q4 2025, with long-term contract prices anticipated to reach a ceiling of C$200 by 2033.
⚛️ Cameco holds a 49% stake in Westinghouse Electric Company, which is developing small modular reactors and securing US government financing for new builds worth at least $80 billion.
🔬 The company owns a 49% interest in Global Laser Enrichment (GLE), which holds an exclusive license for third-generation laser enrichment technology (SILEX).
🌍 There are currently 70 new nuclear reactors under construction globally, with 115 more planned, supporting the transition to zero-carbon baseload power.
📉 Analysts project a one-year share price target of C$185 for Cameco, which recently traded at C$123.
🏦 Cameco maintains a strong balance sheet with net cash of C$0.2 billion and a forward yield of 0.19%.
📊 The company's vertical integration spans the entire spectrum from uranium exploration and mining to fuel fabrication and reactor servicing.
Bullish Signals
- Structural global supply deficit expected to widen significantly after 2033.
- Adjusted diluted EPS surged 321% in 2025 to C$1.44.
- Secured nine-year India contract worth estimated C$2.6 billion.
- Strategic stakes in Westinghouse and GLE offer diversified growth.
- US government financing for AI data centers could value Westinghouse at $15B-$35B.
Bullish Signals
- Cameco is well-positioned for long-term growth due to a structural global supply deficit expected to widen significantly after 2033, allowing the firm to raise production and capture higher pricing power.
- The company's adjusted diluted earnings per share surged 321% in 2025 to C$1.44, driven by rising uranium prices and strong operational performance.
- Cameco secured a massive nine-year contract with India worth an estimated C$2.6 billion, providing revenue visibility extending into the late 2030s.
- Strategic stakes in Westinghouse Electric Company and Global Laser Enrichment (GLE) offer diversified growth opportunities through reactor construction services and advanced enrichment technology.
- The US government is facilitating financing for new nuclear reactors to power AI-heavy data centers, creating a potential IPO opportunity for Westinghouse that could value it at $15 billion-$35 billion.
- Cameco's long-term contract strategy insulates it from spot market volatility while capturing value-added margins through its fuel-manufacturing division.
- Global demand for zero-carbon baseload power is accelerating, with 38 countries signing a declaration to triple nuclear generating capacity by 2050.
Aristotle Capital Management's International Equity Strategy outperformed major benchmarks in Q2 2023, driven largely by securities selection. Cameco Corporation (NYSE: CCJ) was a top contributor to this performance, highlighted as the world's largest publicly traded uranium producer with significant government and policy support for nuclear energy.
The article details Cameco's strong financial position, noting its advantaged assets like the Cigar Lake and McArthur River/Key Lake mines which produce high-grade uranium. The company has successfully ramped up production and secured long-term contracts, including a 12-year deal with Ukraine's Energoatom and a 10-year agreement with Bulgaria, expanding its footprint in Central and Eastern Europe.
Aristotle Capital anticipates further growth from Cameco's planned acquisition of Westinghouse Electric Company, expected to close in the second half of 2023. This deal aims to combine Westinghouse's downstream capabilities with Cameco's production strengths to create a competitive nuclear fuel solution. The stock closed at $36.94 on August 30, 2023, reflecting a 9.55% one-month return.
Despite being held by 54 hedge fund portfolios in Q2 2023 (up from 49 previously), Cameco is not currently on the firm's list of most popular stocks. The investment thesis rests on Cameco's financial discipline, strategic asset quality, and its ability to capitalize on global energy security concerns and the transition away from fossil fuels.
📈 Aristotle Capital International Equity Strategy returned 4.99% gross in Q2 2023.
⛏️ Cameco operates high-grade uranium mines at Cigar Lake and McArthur River.
🤝 Westinghouse acquisition expected to enhance Cameco's downstream fuel services.
🌍 Record long-term supply contracts secured globally including Ukraine and Bulgaria.
🔋 Geopolitics and environmental pledges drive nuclear energy support for Cameco.
📈 Aristotle Capital's International Equity Strategy returned 4.99% gross in Q2 2023, significantly outperforming the MSCI EAFE Index.
🏭 Cameco Corporation (NYSE: CCJ) was identified as a top contributor to the fund's performance due to its status as the world's largest publicly traded uranium producer.
💰 The stock closed at $36.94 per share on August 30, 2023, with a one-month return of 9.55% and a 52-week gain of 29.39%.
🌍 Cameco secured a record number of long-term supply contracts in 2022, continuing into 2023 with new agreements in Ukraine and Bulgaria.
⛏️ The company operates high-grade uranium mines at Cigar Lake and McArthur River/Key Lake, providing a competitive advantage.
🤝 Aristotle Capital expects the planned acquisition of Westinghouse Electric Company to enhance Cameco's downstream fuel services capabilities.
📊 Hedge fund holdings increased slightly in Q2 2023, with 54 portfolios holding shares compared to 49 in the previous quarter.
🔋 Global dynamics, including Russia's war in Ukraine and environmental pledges, are driving increased support for nuclear energy and Cameco's stock.
Bullish Signals
- Top contributor to Aristotle Capital's outperforming strategy in Q2 2023.
- High-grade uranium production at Cigar Lake and McArthur River/Key Lake mines.
- Secured 12-year deal with Ukraine's Energoatom and 10-year agreement with Bulgaria.
- Westinghouse acquisition aligns downstream capabilities for competitive nuclear fuel solution.
Bullish Signals
- Cameco was a top contributor to Aristotle Capital's International Equity Strategy, which significantly outperformed its benchmarks in Q2 2023.
- The company possesses advantaged assets with high-grade uranium production at Cigar Lake and McArthur River/Key Lake mines.
- Cameco has successfully secured long-term contracts, including a 12-year deal with Ukraine's Energoatom and a 10-year agreement with Bulgaria.
- The planned acquisition of Westinghouse Electric Company is expected to align downstream capabilities with production for a competitive nuclear fuel solution.
- Global geopolitical factors like the war in Ukraine have heightened energy security concerns, favoring uranium producers like Cameco.
- Cameco has demonstrated financial discipline and successfully ramped up production while obtaining long-term contracts.
Canada's economy showed resilience in early July, with real gross domestic product growing by 0.3% in May and preliminary estimates indicating further expansion in June. This economic rebound provides a backdrop for increased corporate investment activity across various sectors, including energy and mining.
In the mining sector, Ottawa has granted approval for the construction of a major nickel sulphide mine in Ontario. The project is expected to become the largest of its kind in the western world, utilizing nickel which is critical for stainless steel production and electric vehicle batteries.
The Canadian oil and gas industry is experiencing a strategic shift as producers, having reported significant profits, plan to reinvest excess cash into new production projects rather than maintaining the decade-long trend of financial restraint. This expansion signals renewed confidence in the sector's growth potential.
In the nuclear energy space, Cameco Corp. has initiated steps to list its American subsidiary, Westinghouse, on the U.S. stock market. This move comes amidst a broader boom in nuclear energy and follows the company's headquarters in Saskatoon.
🇨🇦 Canada's real GDP grew 0.3% in May with continued expansion.
✅ Major Ontario nickel mine approved for US$2B construction and US$2.5B total capital.
🔋 Nickel operations will support stainless steel and electric vehicle battery production.
🛢️ Oil producers are investing excess cash into new production projects after profits.
⚡ Cameco Corp. files IPO for Westinghouse nuclear subsidiary on U.S. stock market.
🇨🇦 Canada's real GDP grew by 0.3% in May with June estimates showing continued economic expansion.
✅ Ottawa approved construction of a major Ontario nickel mine expected to be the largest western operation.
💰 The Crawford mine project requires approximately US$2 billion for construction and US$2.5 billion total capital.
🔋 Approved nickel operations will support stainless steel manufacturing and electric vehicle battery production.
🛢️ Canadian oil producers are shifting from a decade of restraint to investing excess cash in new production projects.
🏗️ Energy companies are expanding operations after reporting billions in recent profits.
⚡ Cameco Corp. is filing for an IPO for its Westinghouse nuclear power subsidiary on the U.S. stock market.
📈 The approval of the Ontario mine positions Canada as a key supplier for critical battery metals.
Bullish Signals
- Canada's economy is expanding with GDP growth in May and June, creating a favorable macroeconomic environment for corporate investment.
- Ottawa has approved a major nickel sulphide mine project that will be the largest of its kind in the western world.
- Canadian oil and gas producers are reversing a decade-long trend of financial restraint to invest excess cash into new production projects.
- The approved Ontario mine utilizes nickel, a critical metal for electric vehicle batteries and stainless steel industries.
- Cameco Corp. is advancing its strategic expansion by taking steps to list its Westinghouse subsidiary on the U.S. stock market.
Engle Capital Management L.P. reduced its stake in Cameco Corporation (NYSE: CCJ) by 33.3% during the first quarter, selling 15,397 shares to hold a remaining position of 30,833 shares valued at $3.35 million. This reduction brings Cameco to represent 1.1% of Engle's portfolio, marking it as the firm's 21st largest holding. The filing indicates a shift in institutional positioning for the uranium producer amidst broader market activity.
Several other institutional investors have adjusted their stakes in CCJ during recent quarters. Sterling Capital Management LLC initiated a new stake valued at approximately $30,000, while Nisa Investment Advisors LLC and Founders Capital Management also acquired new positions worth roughly $25,000 and $27,000 respectively. Brown Lisle Cummings Inc. significantly grew its holdings by 3,200%, now owning 297 shares valued at $32,000 after adding to its position in the last quarter.
Analyst sentiment remains mixed with a consensus rating of 'Moderate Buy' and a price target of $146.18. Recent reports include Barclays lowering its price objective to $104 with an 'equal weight' rating, while Bank of America maintained a 'buy' rating but reduced its target to $140. Conversely, Scotiabank issued an 'outperform' rating with a higher $175 price target, and Truist Financial initiated coverage with a 'buy' rating at $129.
Cameco Corporation operates as a leading producer of uranium and supplier to the global nuclear power industry, headquartered in Saskatoon, Saskatchewan. The company is engaged in exploration, mining, milling, and sale of uranium concentrate used for nuclear reactors, operating primarily in Canada and the United States. Financial metrics show a market capitalization of $38.89 billion with a PE ratio of 82.68 and a debt-to-equity ratio of 0.14.
📉 Engle Capital reduced CCJ stake by 33.3% to $3.35 million value.
🏦 Sterling and Nisa initiated new stakes worth $30k and $25k.
📈 Brown Lisle Cummings grew holdings by 3,200% to 297 shares.
💰 CCJ market cap is $38.89 billion with a PE ratio of 82.68.
🎯 Consensus rating is 'Moderate Buy' with a $146.18 price target.
📉 Engle Capital Management L.P. reduced its CCJ stake by 33.3% in Q1, selling 15,397 shares to hold a remaining position valued at $3.35 million.
🏦 Sterling Capital Management LLC and Nisa Investment Advisors LLC initiated new stakes in Cameco worth approximately $30,000 and $25,000 respectively during the first quarter.
📈 Brown Lisle Cummings Inc. grew its CCJ holdings by 3,200% in Q1, now owning 297 shares valued at $32,000 after buying an additional 288 shares.
📊 Founders Capital Management and McGuire Capital Advisors Inc. acquired new positions in Cameco during the fourth quarter valued at roughly $27,000 and $28,000.
🏛️ Institutional ownership of CCJ stands at 70.21%, indicating significant hedge fund and institutional investor interest in the uranium producer.
💰 Cameco Corporation has a market capitalization of $38.89 billion with a PE ratio of 82.68 and a debt-to-equity ratio of 0.14.
📉 Barclays lowered its price objective for CCJ from $108.00 to $104.00 and set an 'equal weight' rating in a July 15th report.
🔼 Scotiabank reissued an 'outperform' rating with a $175.00 price objective, while Bank of America maintained a 'buy' rating but reduced its target to $140.
📈 Truist Financial initiated coverage on CCJ with a 'buy' rating and a $129.00 target price in a July 13th research report.
🎯 The stock currently has a consensus rating of 'Moderate Buy' with a consensus price target of $146.18 based on MarketBeat data.
📉 CCJ opened at $89.29, trading between a 52-week low of $68.96 and a high of $135.24 with a beta of 1.02.
⚙️ The company operates uranium mining and processing properties in Canada and the United States, producing yellowcake for nuclear reactors.
Bullish Signals
- Institutional holdings surged 3,200% in Q1.
- Scotiabank sets $175 price target.
- Debt-to-equity ratio is low at 0.14.
- Current ratio stands strong at 3.08.
Risk Factors
- Engle Capital reduced stake by 33.3%, selling over 15,000 shares.
- Barclays lowered price objective to $104 and downgraded sentiment.
- Bank of America cut target from $143.00 to $140.00.
- Stock trades below 200-day moving average of $110.48 at $89.29.
Bullish Signals
- Institutional investors like Brown Lisle Cummings Inc. significantly increased their holdings by 3,200% in Q1, signaling strong confidence in the company's prospects.
- Multiple analysts maintain 'buy' or 'outperform' ratings, including Scotiabank with a high $175 price target and Truist Financial initiating coverage with a buy rating.
- The company maintains a very strong balance sheet with a debt-to-equity ratio of 0.14 and a current ratio of 3.08, indicating low financial risk.
- New institutional capital is entering the stock, with several firms like Founders Capital Management and McGuire Capital Advisors acquiring new positions in Q4.
Risk Factors
- Engle Capital Management L.P. reduced its stake by 33.3% in Q1, selling over 15,000 shares which may indicate a lack of near-term upside from this specific investor.
- Barclays lowered its price objective to $104 and downgraded the sentiment to 'equal weight', suggesting potential downside or neutral outlook compared to previous targets.
- Bank of America reduced its price target from $143.00 to $140.00, indicating a slight adjustment in valuation expectations despite maintaining a buy rating.
- The stock trades below its 200-day simple moving average of $110.48 and is currently at $89.29, suggesting it may be underperforming recent technical trends.
Cameco Corporation (CCJ) shares received an upgrade to a Buy rating from Neutral by UBS, accompanied by a price target of C$166. This positive action comes after the stock experienced an 18% pullback over the past month, which analysts attribute to broader market sentiment and unrelated AI-related themes rather than any deterioration in Cameco's underlying business fundamentals.
UBS highlights that Cameco's improving fundamentals support the upgrade, suggesting the recent price decline was a market overreaction. The bank's analysis indicates that the company remains well-positioned despite the short-term volatility driven by external macro factors and sector-wide sentiment shifts away from energy or into artificial intelligence narratives.
📈 UBS upgrades Cameco (CCJ) to Buy with C$166 target.
📉 Stock dropped 18% due to AI sentiment, not company issues.
✅ Fundamentals are improving despite recent market correction.
🏦 Analysts attribute decline to external factors, not operational weakness.
📈 UBS upgrades Cameco (CCJ) shares to a Buy rating from Neutral.
💰 Price target set at C$166 following the recent market correction.
📉 Stock has pulled back 18% over the past month due to broader market sentiment.
🤖 Analysts attribute the decline to AI-related sentiment rather than company-specific issues.
✅ Cameco's fundamentals are described as improving despite the price drop.
🏦 UBS believes the recent pullback was driven by external factors, not operational weakness.
Bullish Signals
- UBS upgrades CCJ to Buy with C$166 target.
- Stock is undervalued after recent 18% decline.
- Cameco fundamentals show improving long-term trajectory.
Bullish Signals
- UBS upgrades Cameco (CCJ) to a Buy rating, signaling strong confidence in the company's current valuation and future prospects.
- The bank sets a C$166 price target, implying that the stock is undervalued after its recent 18% decline.
- Analysts note that Cameco's fundamentals are improving, suggesting a positive long-term trajectory for the uranium producer.
Amova Asset Management Americas Inc. significantly increased its stake in Cameco Corporation (CCJ) by purchasing an additional 143,113 shares in the first quarter, representing a 37.7% lift in its position. Following this purchase, Amova holds 522,864 shares valued at approximately $56.8 million according to recent SEC filings. Several other institutional investors also adjusted their positions during the fourth quarter and first quarter, with Clearstead Advisors, Legacy Bridge, HB Wealth Management, Groupama Asset Management, and S.A. Mason all increasing their holdings in the uranium producer.
Analyst sentiment regarding CCJ remains mixed but generally leans positive based on average price targets exceeding current trading levels. Truist Financial initiated coverage with a 'buy' rating and a $129 target price, while Scotiabank maintains an 'outperform' rating with a $175 objective. Conversely, TD Securities downgraded the stock to a 'hold,' and Bank of America recently lowered its price target from $143 to $140, though it retained a 'buy' rating. The consensus average price target stands at $146.18.
Financially, Cameco operates with a strong balance sheet characterized by a low debt-to-equity ratio of 0.14 and healthy liquidity metrics including a current ratio of 3.08. The stock currently trades around $84.84, significantly below its 50-day moving average of $103.12 and 200-day average of $110.75, suggesting potential upside relative to recent technical averages. With a market capitalization of roughly $36.95 billion, the company is viewed as a leading producer of uranium concentrate for the global nuclear power industry.
📈 Amova increased Cameco holdings by 37.7% to 522,864 shares.
💰 Institutional stake valued at $56.8 million per SEC filings.
🎯 Analyst average price target stands at $146.18.
📉 Stock trades at $84.84 below key moving averages.
🏦 Strong balance sheet with 0.14 debt-to-equity ratio.
📈 Amova Asset Management Americas Inc. increased its Cameco holdings by 37.7% in Q1, adding 143,113 shares to a total position of 522,864 shares.
💰 The institutional stake held by Amova is valued at $56,788,000 based on the most recent SEC filing data.
📊 Other major investors including Clearstead Advisors and Legacy Bridge also grew their stakes in Cameco during the fourth quarter.
🎯 Truist Financial initiated coverage with a 'buy' rating and set a $129.00 price target for the stock.
📉 TD Securities downgraded Cameco from a 'strong-buy' to a 'hold' rating in a March report.
💵 Bank of America lowered its price objective from $143.00 to $140.00 while maintaining a 'buy' rating.
📉 The stock currently trades at $84.84, which is below both the 50-day ($103.12) and 200-day ($110.75) moving averages.
🏦 Cameco maintains a robust balance sheet with a debt-to-equity ratio of 0.14 and a current ratio of 3.08.
🌍 The company operates primarily in Canada and the United States, focusing on uranium mining and processing.
📈 MarketBeat data indicates an average analyst price target of $146.18 for Cameco Corporation.
Bullish Signals
- Institutional position increased by 37.7% in Q1.
- Multiple investors added stakes in Q4.
- Low debt-to-equity ratio of 0.14.
- Strong liquidity with current ratio of 3.08.
- Analyst average target $146.18 vs ~$85 price.
Risk Factors
- TD Securities downgraded stock from strong-buy to hold in June.
- Bank of America cut price objective from $143.00 to $140.00.
- Stock at $84.84 trades below 50-day and 200-day moving averages.
Bullish Signals
- Amova Asset Management Americas Inc. significantly increased its position by 37.7% in the first quarter, signaling strong institutional confidence.
- Multiple other institutional investors including Clearstead Advisors and Legacy Bridge also added to their stakes during the fourth quarter.
- The company possesses a very low debt-to-equity ratio of 0.14, indicating minimal financial leverage risk.
- Liquidity is strong with a current ratio of 3.08 and a quick ratio of 2.09.
- Truist Financial initiated coverage with a 'buy' rating and a $129 target price, which is above the current trading level.
- Scotiabank reaffirmed an 'outperform' rating with a high $175.00 price objective.
- Bank of America maintains a 'buy' rating despite lowering its specific price target.
- The average analyst price target of $146.18 suggests significant upside potential from the current trading price of roughly $85.
Risk Factors
- TD Securities downgraded the stock from a 'strong-buy' to a 'hold' rating in June.
- Bank of America recently decreased its price objective from $143.00 to $140.00.
- The current stock price of $84.84 is trading below both the 50-day and 200-day moving averages, indicating recent underperformance.
Bank of New York Mellon Corp increased its holdings in Cameco Corporation (NYSE: CCJ) by 2.4% during the first quarter, purchasing an additional 33,322 shares. The fund's total stake now stands at 1,418,837 shares, valued at $154.1 million as of the latest reporting period.
Several other institutional investors have also adjusted their positions in Cameco recently. Bison Wealth LLC raised its stake by 16.1% to own 21,448 shares worth $1.1 million, while AQR Capital Management and Integrated Wealth Concepts increased their holdings by 16.6% and 48.7% respectively. UBS Asset Management Americas also boosted its position significantly.
Analyst sentiment regarding Cameco remains mixed with a consensus rating of 'Moderate Buy' and a target price of $146.18. While Barclays and TD Securities have downgraded their ratings or lowered price objectives, Truist Financial initiated coverage with a 'Buy' rating and a $129 target. The stock currently trades around $85.61, well below its 50-day moving average of $103.83.
Cameco is a leading producer of uranium and yellowcake, serving the global nuclear power industry with operations primarily in Canada and the United States. The company maintains a strong balance sheet with a debt-to-equity ratio of 0.14 and institutional ownership standing at 70.21%.
🏦 Bank of New York Mellon increased stake to 1,418,837 shares valued at $154.1 million.
📈 Bison Wealth raised position by 16.1% to 21,448 shares worth $1.1 million.
📉 Barclays lowered price objective to $104.00 with an 'equal weight' rating.
💰 Stock trades at $85.61 with a market cap of $37.28 billion and P/E of 79.27.
🛡️ Company maintains robust balance sheet with quick ratio of 2.09 and current ratio of 3.08.
🏦 Bank of New York Mellon Corp increased its Cameco stake by 2.4% to 1,418,837 shares valued at $154.1 million.
📈 Bison Wealth LLC raised its position by 16.1%, now holding 21,448 shares worth $1.1 million.
📊 AQR Capital Management and Integrated Wealth Concepts increased stakes by 16.6% and 48.7% respectively in Q1.
🏛️ UBS Asset Management Americas raised its position by 11.9%, adding 64,512 shares to a total of 604,841.
🆕 NewGen Equity Long Short Fund initiated a new stake valued at approximately $14.25 million in Q2.
📉 Barclays reduced its price objective from $108.00 to $104.00 and set an 'equal weight' rating.
📉 TD Securities downgraded Cameco from 'strong-buy' to 'hold' in a report dated March 26th.
📉 Weiss Ratings lowered the company's rating from 'hold (c+)' to 'hold (c)' on June 4th.
🔼 Truist Financial initiated coverage with a 'buy' rating and a $129.00 price objective on July 13th.
📈 William Blair issued an 'outperform' rating upon starting coverage on April 20th.
💰 The stock currently trades at $85.61 with a market cap of $37.28 billion and a P/E ratio of 79.27.
📉 Cameco's share price is trading below its 50-day moving average of $103.83 and 200-day average of $110.80.
🛡️ The company maintains a robust balance sheet with a quick ratio of 2.09 and current ratio of 3.08.
⚖️ Institutional ownership stands at 70.21% across various hedge funds and asset managers.
🌍 Cameco operates uranium mining and processing properties primarily in Canada and the United States.
Bullish Signals
- BNY Mellon bought 33,322 shares in Q1.
- Bison Wealth raised stake by 16.1%.
- AQR Capital increased position by 16.6%.
- Integrated Wealth Concepts raised position by 48.7%.
- UBS Asset Management added 64,512 shares.
- NewGen Equity invested $14.25 million.
- Truist set price objective at $129.00.
- Institutional ownership stands high at 70.21%.
Risk Factors
- Barclays cut target to $104 and downgraded to equal weight.
- TD Securities downgraded Cameco from strong-buy to hold.
- Weiss Ratings lowered rating from c+ to c in June.
- Stock trades at $85.61, below 50-day average of $103.83.
- Share price is well below 200-day moving average of $110.80.
Bullish Signals
- Bank of New York Mellon Corp increased its investment in Cameco by purchasing an additional 33,322 shares in Q1.
- Bison Wealth LLC raised its stake by 16.1%, adding 2,975 shares to its portfolio.
- AQR Capital Management increased its position by 16.6% by purchasing 1,361 additional shares.
- Integrated Wealth Concepts significantly raised its position by 48.7%, acquiring 2,780 new shares.
- UBS Asset Management Americas increased its stake by 11.9% with a purchase of 64,512 shares.
- NewGen Equity Long Short Fund established a new investment in Cameco valued at $14.25 million.
- Truist Financial initiated coverage with a 'buy' rating and set a price objective of $129.00.
- William Blair issued an 'outperform' rating for the company upon starting coverage.
- The company maintains a very strong liquidity position with a quick ratio of 2.09 and current ratio of 3.08.
- Institutional ownership remains high at 70.21%, indicating continued interest from major investors.
Risk Factors
- Barclays reduced its price objective for Cameco from $108.00 to $104.00 and downgraded the rating to 'equal weight'.
- TD Securities downgraded Cameco from a 'strong-buy' rating to a 'hold' rating.
- Weiss Ratings lowered the company's rating from 'hold (c+)' to 'hold (c)' in June.
- The stock is currently trading at $85.61, which is significantly below its 50-day moving average of $103.83.
- The share price is also trading well below its 200-day moving average of $110.80.
Barlycs has lowered its price target for Cameco (NYSE:CCJ, TSE:CCO) from C$149.00 to C$147.00 in a research note issued on Thursday, July 18th, 2026. Despite this specific downgrade, the consensus analyst sentiment remains positive, with an average rating of 'Moderate Buy' and a consensus target price of C$176.17. The company has received significant support from other major institutions recently; National Bank Financial lifted its target to C$180.00, Royal Bank of Canada raised it to C$175.00, Canaccord Genuity increased it to C$195.00, and both William Blair and Truist Financial upgraded the stock to 'strong-buy' ratings in April and July respectively.
Cameco reported quarterly earnings on May 5th with EPS of C$0.47, a net margin of 18.39%, and revenue of C$845.37 million. The company operates as one of the world's largest uranium producers, with its flagship McArthur River mine in Saskatchewan accounting for approximately 50% of output under normal conditions. To manage through years of uranium price weakness, Cameco has temporarily reduced production at this site and is purchasing from the spot market to fulfill contracted deliveries.
Recent insider activity shows Alexandre Aubin sold 300 shares on June 25th at an average price of C$148.53, reducing his direct ownership by 93.75% to just 20 shares worth C$2,970.60. Corporate insiders collectively own 0.15% of the stock. While the company maintains a strong balance sheet and operational capacity to restart shut mines or invest in new ones for long-term production growth, the immediate market focus is on the divergence between Barclays' pessimistic forecast and the broader analyst consensus.
📉 Barclays cut target to C$147, implying 22.57% upside.
📈 Consensus remains bullish with average target of C$176.17.
🏦 Major institutions recently upgraded or raised their targets.
💰 Q1 earnings showed EPS of C$0.47 and revenue of C$845.37M.
⛏️ McArthur River mine accounts for roughly 50% of uranium output.
📉 Barclays lowered its price target for Cameco from C$149.00 to C$147.00, suggesting a potential upside of 22.57% from the current price.
📈 The broader analyst consensus remains bullish with an average rating of 'Moderate Buy' and a consensus target price of C$176.17.
🏦 Major institutions including National Bank Financial, Royal Bank of Canada, Canaccord Genuity, William Blair, and Truist Financial have recently upgraded or raised their targets for the stock.
💰 Cameco reported Q1 earnings with EPS of C$0.47, a net margin of 18.39%, and revenue of C$845.37 million.
⛏️ The McArthur River mine in Saskatchewan accounts for roughly 50% of the company's uranium output under normal production conditions.
📉 Due to prolonged uranium price weakness, Cameco has reduced production at its flagship mine and is sourcing from the spot market to meet delivery contracts.
👤 Insider Alexandre Aubin sold 300 shares on June 25th for a total value of C$44,559.00, representing a 93.75% decrease in his personal ownership.
🏭 Cameco operates uranium conversion and fabrication facilities in addition to its primary mining operations.
🚀 The company retains the long-term ability to increase annual production by restarting shut mines and investing in new projects.
Bullish Signals
- Consensus target price is C$176.17, implying significant upside potential.
- Major banks raised price targets for Cameco recently.
- William Blair and Truist issued strong-buy ratings.
- Recent quarter net margin was 18.39% with revenue of C$845.37 million.
- Company has flexibility to restart mines or develop new ones.
Risk Factors
- Barclays lowered price target, diverging from other analysts.
- Insider sold 300 shares, reducing stake by 93.75%.
- Production cut at McArthur River mine due to weak prices.
Bullish Signals
- The consensus analyst rating is 'Moderate Buy' with a target price of C$176.17, which implies significant upside potential from recent levels.
- Multiple major banks including National Bank Financial, Royal Bank of Canada, and Canaccord Genuity have recently raised their price targets for Cameco.
- William Blair and Truist Financial have issued 'strong-buy' ratings, indicating strong confidence in the company's long-term prospects.
- Cameco reported a healthy net margin of 18.39% and solid revenue of C$845.37 million in the most recent quarter.
- The company possesses significant operational flexibility to increase production by restarting shut mines or developing new ones.
Risk Factors
- Barclays has issued a pessimistic forecast by lowering its price target, creating a divergence from other major analysts.
- Insider Alexandre Aubin sold 300 shares, reducing his ownership stake by 93.75%, which may signal a lack of confidence at the executive level.
- The company has been forced to reduce production at its flagship McArthur River mine due to years of uranium price weakness.
Barlycs has lowered its price target for Cameco (NYSE:CCJ, TSE:CCO) from C$149.00 to C$147.00 in a research note published on Thursday, July 17th, 2026. This action contrasts with recent upgrades from other major institutions; Canaccord Genuity raised its target to C$195.00 on May 6th, while Scotia, Royal Bank of Canada, TD, and National Bank Financial all increased their targets or maintained buy ratings between May and June.
The company recently reported quarterly earnings on Tuesday, May 5th, delivering C$0.47 per share in earnings per share (EPS) against a revenue of C$845.37 million. Key financial metrics included a return on equity of 9.47% and a net margin of 18.39%. Analyst consensus currently rates the stock as a 'Moderate Buy' with an average price target of C$176.17, reflecting a mix of bullish sentiment from peers and this specific downgrade.
In corporate developments, insider Alexandre Aubin sold 300 shares on June 25th at an average price of C$148.53, reducing his personal ownership by 93.75% to just 20 shares valued at approximately C$2,970.60. Corporate insiders collectively hold only 0.15% of the company's stock. Fundamentally, Cameco remains a major global uranium producer where its flagship McArthur River mine in Saskatchewan typically accounts for half of total output.
Amid years of weak uranium prices, the company has strategically reduced production at its mines and is instead purchasing uranium from the spot market to fulfill contracted delivery obligations. Management maintains that in the long term, Cameco possesses the capacity to increase annual uranium production by restarting previously shut mines and investing in new projects. Additionally, the company operates conversion and fabrication facilities alongside its mining operations.
📉 Barclays cut price target to C$147 from C$149.
📈 Major banks maintain buy ratings or raised targets.
💰 Q1 earnings hit C$0.47 EPS on C$845M revenue.
⛏️ McArthur River mine provides roughly 50% of output.
🔄 Production reduced due to weak uranium prices.
📉 Barclays lowered its price target for Cameco from C$149.00 to C$147.00 in a Thursday research note.
📈 Other major banks including Canaccord Genuity, Scotia, RBC, TD, and National Bank Financial recently raised targets or maintained buy ratings.
💰 Cameco reported Q1 earnings of C$0.47 EPS and revenue of C$845.37 million on May 5th.
📊 The company achieved a return on equity of 9.47% and a net margin of 18.39% for the quarter.
🏦 Analyst consensus remains 'Moderate Buy' with an average price target of C$176.17 based on MarketBeat data.
👤 Insider Alexandre Aubin sold 300 shares on June 25th, reducing his stake by 93.75% to just 20 shares.
⛏️ The flagship McArthur River mine in Saskatchewan accounts for roughly 50% of the company's normal production output.
🔄 Due to uranium price weakness, Cameco has reduced mine production and is purchasing from the spot market to meet contracts.
🚀 Long-term strategy includes restarting shut mines and investing in new projects to increase annual uranium production.
🏭 Cameco operates uranium conversion and fabrication facilities in addition to its mining business.
Bullish Signals
- Analyst upgrades from Canaccord, Scotia, RBC, TD, National Bank show confidence.
- C$0.47 EPS and 18.39% net margin reported in solid quarterly financials.
- Consensus 'Moderate Buy' with C$176.17 price target vs Barclays C$147.00.
- Long-term growth via restarting mines and developing new uranium projects.
Risk Factors
- Barclays lowered target to C$147.00.
- Insider sold 300 shares for C$44,559.
- Reduced production due to weak uranium prices.
Bullish Signals
- Recent analyst upgrades from Canaccord Genuity, Scotia, Royal Bank of Canada, TD, and National Bank Financial indicate strong institutional confidence despite the Barclays downgrade.
- The company reported solid quarterly financials with C$0.47 EPS and a healthy net margin of 18.39%.
- Cameco maintains a 'Moderate Buy' consensus rating with an average price target of C$176.17, which is significantly higher than the specific Barclays target of C$147.00.
- The company has long-term growth potential to increase annual uranium production by restarting shut mines and developing new projects.
Risk Factors
- Barclays specifically lowered its price target from C$149.00 to C$147.00, signaling a bearish view on the current valuation or outlook.
- Insider Alexandre Aubin sold 300 shares for approximately C$44,559, reducing his ownership by 93.75% which may signal a lack of confidence at that price level.
- The company has been forced to reduce production from its flagship McArthur River mine and purchase uranium from the spot market due to years of weak uranium prices.
Calamos Advisors LLC increased its position in Cameco Corporation (CCJ) by 21.7% during the first quarter, acquiring an additional 10,656 shares to hold a total of 59,794 shares valued at $6.494 million according to recent SEC filings.
Several other institutional investors have also adjusted their stakes in Cameco recently, including new positions from Nisa Investment Advisors, Founders Capital Management, and McGuire Capital Advisors, while Caitong International Asset Management significantly lifted its position by 30,700%.
Analyst sentiment remains mixed with Scotiabank and Sanford C. Bernstein maintaining 'outperform' ratings with price targets of $175 and $135 respectively, though TD Securities downgraded the stock to a 'hold'. The consensus rating is currently a 'Moderate Buy' with an average price target of $146.52.
Cameco operates as a leading uranium producer headquartered in Canada with operations in both Canada and the United States. Financial metrics show a market capitalization of $39.93 billion, a P/E ratio of 84.89, and strong liquidity ratios, though the stock is currently trading below its 50-day and 200-day moving averages.
📈 Calamos Advisors increased CCJ holdings by 21.7% to $6.494 million.
🏦 Nisa Investment and Founders Capital established new Cameco stakes in Q4.
💰 Scotiabank targets $175 while TD Securities downgraded to 'hold'.
📉 Stock trades at $91.68, below 50-day and 200-day moving averages.
⚖️ Low debt-to-equity of 0.14 indicates minimal leverage for the producer.
📈 Calamos Advisors increased its CCJ holdings by 21.7% in Q1 to own 59,794 shares valued at $6.494 million.
🏦 Multiple hedge funds including Nisa Investment and Founders Capital established new stakes in Cameco during the fourth quarter.
📉 Caitong International Asset Management lifted its position by 30,700% to own 308 shares valued at $28,000.
📊 Institutional ownership of CCJ stands at 70.21% as of the latest filing data.
💰 Scotiabank reiterated an 'outperform' rating with a $175 price objective for Cameco shares.
⚠️ TD Securities downgraded Cameco from 'strong-buy' to 'hold' in a March 26th research note.
🎯 Sanford C. Bernstein reaffirmed an 'outperform' rating with a $135 price target on June 15th.
📉 The stock currently trades at $91.68, below its 50-day moving average of $105.73 and 200-day average of $110.91.
💵 Cameco has a market cap of $39.93 billion with a P/E ratio of 84.89 and a beta of 1.02.
🛡️ The company maintains strong liquidity with a quick ratio of 2.09 and current ratio of 3.08.
⚖️ Debt-to-equity is low at 0.14 indicating minimal leverage for the uranium producer.
📝 Thirteen analysts rate CCJ as Buy while five analysts have issued Hold ratings.
Bullish Signals
- Calamos Advisors increased stake by 21.7% in Q1.
- Scotiabank maintains $175 price objective rating.
- Sanford C. Bernstein reaffirmed $135 target rating.
- Quick ratio of 2.09 and current ratio of 3.08.
- Debt-to-equity ratio is only 0.14.
Risk Factors
- TD Securities downgraded stock from strong-buy to hold.
- Weiss Ratings cut rating from c+ to c.
- Stock trades below 50-day and 200-day moving averages.
Bullish Signals
- Calamos Advisors significantly increased its stake by 21.7% in Q1, signaling institutional confidence in the company's fundamentals.
- Scotiabank maintains an 'outperform' rating with a high $175 price objective, suggesting potential upside from current levels.
- Sanford C. Bernstein reaffirmed an 'outperform' rating with a $135 target, supporting bullish analyst sentiment.
- Cameco possesses strong balance sheet metrics including a quick ratio of 2.09 and current ratio of 3.08.
- The company has minimal debt exposure with a debt-to-equity ratio of only 0.14.
Risk Factors
- TD Securities downgraded the stock from 'strong-buy' to 'hold', indicating some analysts see limited near-term upside.
- Weiss Ratings cut the rating from 'hold (c+)' to 'hold (c)', reflecting a slight reduction in credit or quality outlook.
- The stock is currently trading below its 50-day and 200-day moving averages, suggesting recent underperformance relative to technical trends.
This article compares uranium stocks Energy Fuels Inc. (UUUU) and Cameco Corporation (CCJ), analyzing their operational performance, growth outlooks, and risk profiles within the strengthening global nuclear energy cycle. Energy Fuels is highlighted for its U.S.-based production, debt-free balance sheet, and recent surge in Q1 2026 revenues of $35.8 million, driven by a 112% year-over-year increase. The company is also expanding into rare earth elements (REEs) with successful pilot-scale terbium oxide production and plans to acquire Australian Strategic Materials.
Cameco Corporation is presented as a global leader with tier-one operations producing over 30 million pounds of uranium concentrates annually, accounting for 15% of global production in 2025. While Cameco reported adjusted earnings per share growth of 194% to CAD 0.47 in Q1 2026, its full-year 2026 revenue guidance indicates a projected 7% decline due to lower uranium deliveries and softer market conditions. The company maintains strong contract visibility with commitments for over 28 million pounds of annual deliveries over the next five years.
The analysis concludes that Energy Fuels offers a compelling growth case supported by accelerating production, improving cost economics from low-cost ore processing, and diversification into REEs, despite trading at a higher forward P/S multiple of 17.47X compared to Cameco's 15.39X. Conversely, Cameco is valued for its scale, stability, and deep integration across the nuclear fuel cycle, though it faces near-term headwinds from operational disruptions like flooding in Saskatchewan and mill outages.
📈 Energy Fuels Q1 2026 revenue surged 112% to $35.8 million.
⛏️ Energy Fuels targets 2-2.5M lbs uranium in 2026 with contracts through 2032.
💰 Cameco Q1 2026 adjusted EPS grew 194% to CAD 0.47.
📉 Cameco guides 2026 revenue between CAD 3.13-3.37 billion.
🌍 Cameco holds 15% of global uranium production with tier-one ops.
📈 Energy Fuels Q1 2026 revenues surged 112% year-over-year to $35.8 million, narrowing the quarterly loss to four cents per share from 13 cents a year ago.
⛏️ Energy Fuels expects to mine 2-2.5 million pounds of uranium in 2026 and has secured six supply contracts with U.S. nuclear utilities covering deliveries through 2032.
🔬 Energy Fuels achieved the first U.S. primary production of high-purity terbium oxide in decades and plans to expand NdPr capacity at its White Mesa Mill to approximately 6,229 tpa.
💰 Cameco reported adjusted earnings per share growth of 194% year-over-year to CAD 0.47 in Q1 2026, driven by higher revenues and equity earnings from its Westinghouse stake.
📉 Cameco guides total 2026 revenues between CAD 3.13-3.37 billion, representing a 7% year-over-year decline at the midpoint due to lower uranium delivery targets.
🌍 Cameco accounts for 15% of global uranium production in 2025 with tier-one operations capable of producing over 30 million pounds of uranium concentrates annually.
🏭 Energy Fuels commenced processing low-cost Pinyon Plain mine ores in Q4 2025, expected to lower costs of goods sold to the $30-$40 per pound range for the remainder of 2026.
🤝 Cameco has secured contracts requiring average annual uranium deliveries of more than 28 million pounds per year over the next five years, ensuring long-term revenue visibility.
⚠️ Operational disruptions at Cameco's Key Lake mill and Cigar Lake mine due to flooding and milling issues temporarily halted production but are not expected to materially impact 2026 guidance.
📊 Energy Fuels trades at a forward price-to-sales multiple of 17.47X, while Cameco trades at 15.39X, reflecting the market's preference for Energy Fuels' growth trajectory.
Bullish Signals
- Energy Fuels Q1 2026 revenues up 112% to $35.8 million.
- Narrowed quarterly loss to 4 cents from 13 cents a year ago.
- Secured six uranium supply contracts with U.S. nuclear utilities through 2032.
- Cameco adjusted EPS surged 194% to CAD 0.47 in Q1 2026.
- Produced first U.S. primary high-purity terbium oxide at White Mesa Mill.
- Cameco has commitments for over 28 million pounds of annual uranium deliveries.
- Received conditional $725 million financing commitment from U.S. Office of Strategic Capital.
- Cameco increased Cigar Lake ownership to 57.418% enhancing production capacity.
Risk Factors
- Energy Fuels costs rose 18.5% due to higher uranium sales volumes.
- Cameco 2026 revenues decline 7% to CAD 3.13-3.37 billion.
- McClean Lake mill outage risks prolonged mining halt at Cigar Lake.
- Cameco 2026 deliveries target 29-32 million pounds, down from 33 million.
- Energy Fuels expenses up 24% amid Roca Honda permitting advances.
Bullish Signals
- Energy Fuels Q1 2026 revenues increased 112% year-over-year to $35.8 million, demonstrating strong demand and operational scaling.
- Energy Fuels narrowed its quarterly loss to four cents per share from 13 cents a year ago despite rising costs, indicating improving profitability dynamics.
- Energy Fuels has secured six uranium supply contracts with U.S. nuclear utilities covering deliveries from 2026 to 2032, providing significant revenue visibility.
- Cameco achieved a 194% surge in adjusted earnings per share year-over-year to CAD 0.47 in Q1 2026, driven by strong uranium segment performance.
- Energy Fuels successfully produced high-purity terbium oxide at the White Mesa Mill, marking the first U.S. primary production of this critical heavy REE in decades.
- Cameco maintains excellent contract visibility with commitments for over 28 million pounds of annual uranium deliveries over the next five years.
- Energy Fuels received a conditional commitment for up to $725 million in financing from the U.S. Office of Strategic Capital to support critical mineral processing expansion.
- Cameco increased its ownership in Cigar Lake to 57.418%, enhancing its production capacity and strategic position in Saskatchewan's uranium deposits.
Risk Factors
- Energy Fuels costs applicable to revenues rose 18.5% year-over-year due to higher uranium sales volumes and elevated production costs.
- Cameco guides total 2026 revenues of CAD 3.13-3.37 billion, indicating a 7% year-over-year decline at the midpoint compared to 2025.
- Operational issues at Cameco's McClean Lake mill temporarily halted mining at Cigar Lake, posing a potential risk if outages prolong beyond current expectations.
- Cameco's uranium deliveries are targeted at 29-32 million pounds for 2026, which is lower than the 33-million pounds delivered in 2025.
- Energy Fuels faces elevated production costs and increased exploration, development, and processing expenses of 24% year-over-year as it advances permitting at the Roca Honda Project.
